September 4, 2015 News by Marta Silva Mylan Confirms Continued Patent Proceedings Concerning MS Therapy Copaxone According toĀ a press release from Mylan N.V., the U.S. Patent and Trademark Office (PTO) has issuedĀ an inter partes review (IPR) proceeding on all claims against a third Copaxone patent for the 40 mg/mL (U.S. Patent No. 8,969,302) formulationĀ by Yeda Research & Development Co., Ltd.
February 10, 2015 News by Patricia Silva, PhD Creative Medical Seeks Patent for Stem Cell Therapy for MS Phoenix, Arizona-basedĀ Creative Medical Health (CMH) has just announced it has submitted a patent application for its proprietary mesenchymal stem cell pipeline product, indicated for autoimmune diseases. The companyĀ is already preparing to launch the product into its first line of clinical tests, which will…